Table 1 Baseline characteristics of patients.

From: Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept

Variables

MC n (%)

BSC n (%)

P values

Total

35

70

 

Sex

  Male

27 (77%)

57 (81.4%)

0.613

  Female

8 (23%)

13 (18.6%)

 

Age median (range)

65 (43–88)

69 (37–91)

0.136

BCLC

  B

15 (42.8%)

30 (42.8%)

1.000

  C

20 (57.2%)

40 (57.2%)

 

Extra-hepatic spread

9 (25.7%)

12 (17.1%)

0.312

Macrovascular Invasion

14 (40%)

29 (41.4%)

1.000

ECOG - PS

  0

23 (65.7%)

39 (55.6%)

0.401

  1–2

12 (34.3%)

31 (44.4%)

 

Child-Pugh score

  B7

18 (51.4%)

43 (61.4%)

0.402

  B8-B9

17 (48.6%)

27 (38.6%)

 

AFP > 400 ng/mL

11 (31.4%)

20 (30.0%)

1.000

Etiology

  HBV

6 (17.1%)

8 (11.4%)

 

  HCV

18 (51.4%)

37 (52.8%)

0.703

  Non-viral

11 (31.4%)

25 (35.7%)